We’re proud to announce the very latest updates to the 2nd Annual Biotech and Money London conference. With the addition of some heavy hitting keynotes including Jim Mellon, Serial Entrepreneur and Founder, Mann Bioinvest and Cathrin Petty, Head of European Healthcare Banking, JP Morgan, plus fantastic additions to our Pharma Forum Day you have every reason to secure your place at next February’s congress.

DOWNLOAD the new brochure and it’s updates here to see new speakers, new sessions, who is speaking where and to get an appreciation of the scale of the 2016 event.

Keynote participants now include:

• Sir Chris Evans OBE, Chairman, Excalibur Group
• Jim Mellon, Serial Entrepreneur and Founder, Mann Bioinvest
• Dennis Purcell, Founder, Aisling Capital
• Andy Smith, CIO, Mann Bioinvest
• Darrin Disley, CEO, Horizon Discovery
• Peter George, CEO, Clinigen
• Russ Cummings, CEO, Imperial Innovations
• Nigel Pitchford, CIO, Imperial Innovations
• Peter Dines, Head of Life Sciences, Mercia Fund Management
• Cathrin Petty, Head of European Healthcare Banking, JP Morgan
• Robert Tansley, Investment Director, Cambridge Innovation Capital

Over 40 active investors, funds and networks are already signed up. Plus confirmed Pharma BD&L representation from GSK, Astrazeneca, Ipsen Biopharm, Pfizer, Novartis and Sanofi with many more confirming daily.

Just some of the key features of the 2nd annual Biotech and Money London:

• Keynotes on UK Life Science Investment and Patient Capital
• Discussion groups across the full spectrum of the funding and partnering lifecycle
• A C-level audience from spin outs, start-ups, SMEs and mid cap public and private Co’s
• Session formats to encourage interaction, peer-to-peer debate and real outcomes
• A event in which to access capital, funding sources and strategic partners
• We bring the inventors and entrepreneurs with commercial potential
• Online meeting planner plus dedicated onsite 1-2-1 partnering room